Documentdetail
ID kaart

doi:10.1186/s13256-023-03868-3...

Auteur
Bazvand, Fatemeh Riazi-Esfahani, Hamid Salari, Farhad
Langue
en
Editor

BioMed Central

Categorie

Medicine & Public Health

Jaar

2023

vermelding datum

29-03-2023

Trefwoorden
niclosamide drug toxicity bull’s-eye maculopathy retinopathy maculopathy retinal veterinary
Metriek

Beschrijving

Background To report the first case of bull’s eye maculopathy associated with veterinary niclosamide.

Case presentation A 27-year-old Iranian female presented with a history of reduced vision and photopsia since 3 years, after accidental ingestion of four boluses of veterinary niclosamide.

Fundus examination showed atrophy in parafoveal retinal pigmentary epithelium, appearing as bilateral bull’s-eye maculopathy.

Optical coherence tomography revealed disruption of the parafoveal ellipsoid zone and outer retinal thinning, appearing as a flying saucer sign.

Electroretinography displayed decreased scotopic and photopic amplitudes with normal waveform in both eyes.

The causality score was 4, showing “possible” retinopathy due to niclosamide according to Naranjo’s causality assessment algorithm.

Based on clinical and ancillary findings, a diagnosis of niclosamide-induced maculopathy was made.

Conclusion Veterinary niclosamide is an anthelmintic drug that in higher doses could be detrimental to the human retina.

Awareness about its side effects and appropriate drug labeling could prevent accidental toxicity.

Bazvand, Fatemeh,Riazi-Esfahani, Hamid,Salari, Farhad, 2023, Presumed veterinary niclosamide-induced retinal toxicity in a human: a case report, BioMed Central

Document

Openen

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw